Studies

I-PRESERVE

I-WOTCH

IABP-SHOCK II

ICAP

Icatibant in ACEi-induced angioedema

iCBT (secondary analysis, guided iCBT vs. self-guided iCBT)

iCBT (secondary analysis, guided iCBT vs. usual treatment)

ICE-CUB 2

ICG-COLORAL

ICHADAPT-2

ICON7

ICTOC

ICU-diary

ICU-ROX

ICU-VR

IDEAL

IDEAL-ICU

iDIAPASON

IFR-SWEDEHEART

IIHTT

Iloprost in Traumatic Hemorrhagic Shock

ILUMIEN IV OPTICAL PCI

Imatinib-IPF

IMB-NIV program for CHRF

IMbrave 150

IMMUNOCITRE

IMPACT (cancer pain)

IMPACT (triple therapy vs. fluticasone/vilanterol)

IMPACT (triple therapy vs. umeclidinium/vilanterol)

IMpower133

ImpresU

IMPROVE

IMPROVE-IT

IMROZ

IMvoke010

IMweanT

Inappropriate Stress Ulcer Prophylaxis in ICU

INAVO120

IND227

INDIGO

INHALE WP3

innovaTV 301

INPULSIS

INSEMA

INSIGHT START

INSPIRATION-S

INSPIRE 3

INSPIRE 4

INSPIRE-ASP PNA

INSPIRE-ASP UTI

INSPIRES (antiplatelet therapy)

INSPIRES (statin therapy)

INSTINCT

INTEGUMENT-1

INTEGUMENT-2

INTERACT2

Intravenous lidocaine after hepatectomy

INTREPID

INVESTED (secondary analysis)

INVICTUS

iPEGASUS

IPrEx

IRAKLIA

IRIS

IRONMAN

IRONOUT-HF

ISAR-TRIPLE

ISAT 1

ISCHEMIA

iSEARCH

ITAC

ITACTIC

IV Thyroxine for Heart-Eligible Organ Donors

IVERCOR-COVID19

IVIG for Kawasaki Disease

IVIO